4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001209191-18-039519
Options or other derivatives
- Director acquired 187,330 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| MOTT DAVID M Director | 2018-06-22 | Grant or award · Option to purchase Ordinary Shares | +187,330 | 187,330 | D | ||
Loading xslF345X03/doc4.xml…